Anti-infective Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Each of the market segments has been extensively analyzed based on market related factors such as incidence and prevalence of pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, and respiratory virus infection. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the anti-infective drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global anti-infective drugs market.

Geographically, the global anti-infective drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global anti-infective drugs market.

Key players operating in the global anti-infective drugs market are Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson, among others.

The global anti-infective drugs market has been segmented as follows:

Global Anti-infective Drugs Market, by Type

Anti-bacterial Drugs
B-lactams
Quinolones
Macrolides
Tetracycline
Aminoglycoside
Others (sulfonamide, phenicols)
Anti-fungal Drugs
Azoles
Echinocandins
Polyenes
Others
Anti-viral Drugs

Global Anti-infective Drugs Market, by Indication

Pneumonia
Methicillin-resistant Staphylococcus Aureus (MRSA)
Sepsis
Tuberculosis
Dermatophytosis
Aspergillosis
Candidiasis
Hepatitis Virus Infection
HIV Infection
Respiratory Virus Infection
Others

Global Anti-infective Drugs Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Sales

Global Anti-infective Drugs Market, by Region

North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.